ACTICOR BIOTECH SAS |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.92 EUR | -1.08% |
|
+9.52% | -68.28% |
| 05-15 | Acticor: 'new perspectives' in stroke treatment | CF |
| 05-15 | Acticor Biotech Announces Presentation of the Main Results of the Phase 2/3 Actisave Study in the Treatment of Stroke at ESOC 2024 | CI |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ACTICOR BIOTECH SAS | Bio Therapeutic Drugs | -1.08% | +9.52% | -68.28% | -84.92% | - | 13.12M |  |  | |
- Stock Market
- Equities
- ALACT Stock
- Charts Acticor Biotech SAS
- Relative Strength Chart
